Ann Graybiel

First Person | Ann Graybiel Courtesy of MIT Talk to neuroscientist Ann Graybiel for a short period of time and she immediately generates certain impressions: The words tenacious, steadfast, and curious come to mind. Since 1971, Graybiel has stayed the course at the Massachusetts Institute of Technology, studying basal ganglia, discerning their architecture and describing their neurochemical organization. Known to the press as the woman who studies how behavior becomes habit, Graybiel is co

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Talk to neuroscientist Ann Graybiel for a short period of time and she immediately generates certain impressions: The words tenacious, steadfast, and curious come to mind. Since 1971, Graybiel has stayed the course at the Massachusetts Institute of Technology, studying basal ganglia, discerning their architecture and describing their neurochemical organization. Known to the press as the woman who studies how behavior becomes habit, Graybiel is content where she is. "I haven't felt compelled to go someplace else. Right now, MIT is bursting with energy for neuroscience."

With 200-plus papers to her credit, as well as the National Medal of Science, Graybiel also seems an ideal lab head: She declined to name her favorite papers, a standard question of this feature. She didn't want to offend any of her coworkers by choosing one over another.

What questions were neuroscientists asking when you started? How do we see? How can we use ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies